Pathway B: Metabolic dysfunction associated steatotic liver disease (MASLD) (Guidelines

Warning

Audience

  • Adults only
  • NOT for use in children or pregnant women

Non alcoholic fatty liver disease pathway

Asymptomatic Abnormal LFTs

  • If clinical signs of cirrhosis or any red flag symptoms: refer urgently

MD CALC: Fib 4 calculator

Full liver screen:

  • Includes USS, liver bloods including GGT and AST, Hep B surface antigen, Hep C antibodies, AMA, ASMA and ANA antibodies, serum immunoglobulins and simultaneous ferritin and transferrin saturations

 

Editorial Information

Last reviewed: 20/07/2021

Next review date: 20/07/2024

Author(s): Liver guideline and pathway group.

Version: V1.2

Approved By: TAM subgroup of ADTC

Reviewer name(s): Dr A Broad, Consultant Gastroenterologist and Liver nurse specialist..

Document Id: TAM672

Related resources

Further information for Health Care Professionals: